IMDX vs TEL · rev $1.9M vs P/E 39, rev $17.26B
Insight Molecular Diagnostics Inc. (IMDX) versus TE Connectivity Ltd (TEL) — a side-by-side from cached financials, not a winner call.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
TE Connectivity Ltd (TEL) is a electronic components company listed on US.
Latest reported IMDX revenue for 2024-12-31 was $1.9M. Net income was -$60.7M. Revenue was up 25.1% from 2023-12-31 to 2024-12-31. IMDX currently screens at market cap $0.
Latest reported TEL revenue for 2025-09-26 was $17.26B. Net income was $1.84B. Revenue was up 8.9% from 2024-09-27 to 2025-09-26. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
IMDX currently screens at market cap $0. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
Not investment advice. Open the IMDX and TEL stock pages for the full models.
Not investment advice.